Category Archives:

(Reuters) - Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Delib...

By Saqib Iqbal Ahmed NEW YORK (Reuters) - A selloff in U.S. government bonds is jolting everything from stocks to the real estate market, as investors recalibrate their portfolios amid a surge in Trea...

By Dan Levine and Hyunjoo Jin SAN FRANCISCO (Reuters) - A Tesla engineer in court on Wednesday rejected a lawyer's suggestion that the company named its driver-assistant feature "Full Self-Driving" be...

By Max A. Cherney (Reuters) - Artificial intelligence chipmaker Graphcore said it needed to raise cash due to widening losses, according to a filing, as Nvidia's dominance in AI chips has chilled fund...

(Reuters) - She is only 21 but Billie Eilish already has a comic book published about her life, highlighting her journey from young dancer to Oscar-winning songwriter. Publisher TidalWave Comics has a...

EAST PEORIA, Ill. – Ground is officially being broken on what’s being called a luxury apartment complex in East Peoria. “Blutowne” is expected to be complete around Fall, 2025,...

NEW YORK (Reuters) - The former campaign treasurer for U.S. Representative George Santos, who has been indicted on fraud charges, has been arrested and is expected to plead guilty to unspecified crimi...

By Ana Mano SAO PAULO (Reuters) - Brazilian labor prosecutors have requested a court order to ban the use of atrazine, which is present in 5% of pesticides sold in the country, the prosecutors said on...

By Marcelo Teixeira NEW YORK (Reuters) - Most of the record physical delivery of sugar by commodities traders at the expiration of the October futures contract at the Intercontinental Exchange (ICE) l...

By Daniel Wiessner (Reuters) - A lawyer for the state of Texas on Thursday told a U.S. appeals court President Joe Biden's administration has no power to force the state to remove a 1,000-foot (305-me...